Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Investors remain optimistic about ICON (ICLR) due to its commitment to patient access and impressive strategic pacts.
Icon PLC (ICLR) reported earnings 30 days ago. What's next for the stock?
ICON's (ICLR) second-quarter 2024 results reflect efficient service delivery and strong cost control.
Icon PLC (ICLR) came out with quarterly earnings of $3.75 per share, beating the Zacks Consensus Estimate of $3.69 per share. This compares to earnings of $3.11 per share a year ago.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Icon PLC (ICLR) is well positioned to outperform the market, as it exhibits above-average growth in financials.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Investors with an interest in Medical Services stocks have likely encountered both Icon PLC (ICLR) and GoodRx Holdings, Inc. (GDRX). But which of these two stocks is more attractive to value investors?
ICON acquired PRA Health Sciences in a $12B deal in 2020, creating a new company. The stock has doubled since the acquisition, and could be worth $370-$400/share based on earnings estimates and excess earnings above assets of similar price and risk. Its strong order book, earnings leverage, and attractive valuations support a buy recommendation.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Icon PLC (ICLR) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.